Patents on tetracycline and tetracycline derivatives as antimicrobials: January 1998 – October 2002

Bibliography

• LEVY SB: Antibiotic resistance microbial adaptation and evolution. In: The Antibiotic Paradox. How the Misuse of Antibiotics Destroys Their Curative Powers. Levy SB (Ed.), Perseus Publishing, Cambridge, MA, USA (2002).
   Google Scholar
• ••An historical overview of the use ofantibiotics and the emergence of antibiotic resistance. Written for those with and without formal training on the subject.
   Google Scholar
• CHOPRA I, ROBERTS M: Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbial. MM. Biol. Rev (2001) 65(2):232–260.
   PubMed Web of Science ®Google Scholar
• ••A current comprehensive review with 319citations spanning the discovery and development of the tetracyclines to their uses and resistance problems.
   Google Scholar
• FINCH RG: The tetracyclines. In: Antibiotic and Chemotherapy O'Grady F, Lambert HP, Finch RG, Greenwood D (Eds), Churchill Livingstone, Edinburgh, UK (1997) 469–484.
   Google Scholar
• CUNHA BA: Doxycycline re-revisited. Arch. Intern. Med. (1999) 159:1006–1007.
   PubMedGoogle Scholar
• BENAVIDES S, NAHATA MC: Anthrax: safe treatment for children. Ann. Pharmacotherapy (2002) 36(2):334–337.
   PubMedGoogle Scholar
• MCMURRY LM, LEVY SB: Tetracycline resistance in Gram-positive bacteria. In: Cram-Positive Pathogens. Fischetti VA (Ed.), American Society for Microbiology, Washington DC. USA (2000) 660–677.
   Google Scholar
• •A review with 149 citations detailing the tetracycline-specific determinants for Gram-positive bacteria.
   Google Scholar
• SCHNAPPINGER D, HILLEN W: Tetracyclines: antibiotic action, uptake and resistance mechanisms. Arch. Microbial. (1996) 165:359–369.
   PubMed Web of Science ®Google Scholar
• CHOPRA I: Glycylcyclines: third generation tetracycline antibiotics. Can: Opin Pharmacol (2001) 1:464–469.
   PubMedGoogle Scholar
• •A quick overview of the current developments of the third-generation tetracycline class.
   Google Scholar
• LAWRENCE LE, BARRETT JF: Efflux pumps in bacteria: overview, clinical relevance, and potential pharmaceutical target. Expert Opin. Investig. Drugs (1998) 7(2):199–207.
   PubMedGoogle Scholar
• MURAKAMI K, TATEDA K, MATSUMOTO T, MIYAZAKI S, YAMAGUCHI K: Efficacy of a novel tetracycline derivative, glycylcycline, against penicillin-resistant Streptococcus pneumoniae in a mouse model of pneumonia. J. Antimicrobial Chemother. (2002) 46:629–631.
   Google Scholar
• VAN OGTROP ML, ANDES D, STAMSTAD TJ et al.: In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various Gram-positive and Gram-negative bacteria. Antimicrob. Agents Chemother. (2000) 44(4):943–949.
   PubMed Web of Science ®Google Scholar
• HUNTER PA, CASTANER J: GAR-936; tigecycline; TBG-MINO; WAY-GAR-936: tetracycline antibiotic. Drugs of the Future (2001) 26(9):851–858.
   Google Scholar
• CARTER AP, CLEMONS WM, BRODERSEN DE, MORGAN-WARREN RJ, WIMBERLY BT, RAMAKRISHNAN V: Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature (2000) 407:340–348.
   PubMed Web of Science ®Google Scholar
• PIOLETTI M, SCHLUNZEN F, HARMS J et al.: Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3. EMBO (2001) 20(8):1829–1838.
   PubMed Web of Science ®Google Scholar
• BRODERSEN DE, CLEMONS WM Jr, CARTER AP, MORGAN-WARREN RJ, WIMBERLY BT, RAMAKRISHNAN V: The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell (2000) 103:1143–1154.
   PubMed Web of Science ®Google Scholar
• NOAH JW, DOLAN MA, BABIN P, WOLLENZIEN P: Effects of tetracycline and spectinomycin on the tertiary structure of ribosomal RNA in the Escherichia coil 30S ribosomal subunit. J. Biol. Chem. (1999) 274(23):16576–16581.
   PubMedGoogle Scholar
• NELSON ML: Tetracyclines in Biology Chemistry and Medicine. Nelson M, Hillen W, Greenwald RA (Eds), Springer, Heidelberg, Germany (2002).
   Google Scholar
• •A book that features chapters devoted to a variety of historical and current topics relating to the tetracyclines.
   Google Scholar
• MENDEZ B, TACHIBANA C, LEVY SB: Heterogeneity of tetracycline resistance determinants. Plasmid (1980) 3:99–108.
   PubMedGoogle Scholar
• BEN VENISTA R, DAVIES J: Aminoglycoside antibiotic-inactivation enzymes in actinomycetes similar to those present in clinical isolates of antibiotic resistant bacteria. Proc. Natl. Acad. Sci. (1973) 172:3628–3632.
   Google Scholar
• ROBERTS MC:Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol Rev (1996) 19(1):1–24.
   PubMed Web of Science ®Google Scholar
• ••A comprehensive review with 131 referencesdiscussing the genetic basis of tetracycline resistance.
   Google Scholar
• DAILIDIENE D, BERTOLI MT et al.: Emergence of tetracycline resistance in Helicobacterpy/ori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob. Agents Chemother. (2002) 46(12):3940–3946.
   PubMedGoogle Scholar
• ROSS JI, EADY EA, COVE JH, CUNLIFFE WJ: 16S rRNA mutation associated with tetracycline resistance in a Gram-positive bacterium. Antimicrob. Agents Chemother: (1998) 42M:1702–1705.
   Google Scholar
• LEVY SB: Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother. (1992) 36:695–703.
   PubMed Web of Science ®Google Scholar
• NELSON ML: Modulation of antibiotic efflux in bacteria. Curt: Med. Chem: Anti-Infective Agents (2002) 1(1)35–54.
   Google Scholar
• GRKOVIC S, BROWN MH, SKURRAY RA: Regulation of bacterial drug export systems. MicrobioL Ma Biol. Revs.(2002) 66(4):671–701.
   PubMed Web of Science ®Google Scholar
• YAMAGUCHI A, AKASAKA T, ONO N et al.: Metal-tetracycline/H+ antiporter of Escherichia coliencoded by a transposon Tn10. Histidine 257 plays an essential role in HF translocation. Biol. Chem. (1991) 266:6045–6051.
   Google Scholar
• MCMURRY LM, PETRUCCI R, LEVY SB:Active efflux of tetracycline encoded by four genetically different resistance determinants in E. colt. Proc. Natl. Acad. Sci. (1980) 77:3974–3977.
   PubMed Web of Science ®Google Scholar
• HILLEN W, BERENS C: Mechanisms underlying expression of Tnl 0 encoded tetracycline resistance. Ann. Rev Microbial. (1994) 48:345–369.
   PubMed Web of Science ®Google Scholar
• GUAY GG, TUCKMAN M, ROTHSTEIN DM: Mutations in the tetA (B) gene that cause a change in substrate specificity of the tetracycline efflux pump. Antimicrob. Agents Chemother. (1994) 38:857–860.
   PubMed Web of Science ®Google Scholar
• OHNUKI T, KATOH T, IMANAKA T, AIBA S: Molecular cloning of tetracycline resistance genes from Streptomyces rimosus and Smeptomyces grisues and characterization of the cloned genes. Bacteria (1985) 161:1010–1016.
   PubMedGoogle Scholar
• TAYLOR DE, CHAU A: Tetracyline resistancemediated by ribosomal protection. Antimicrob. Agents Chemother. (1996) 40(1):1–5.
   PubMed Web of Science ®Google Scholar
• •A mini-review that provides a core understanding of tetracycline resistance caused by ribosomal protection mechanisms.
   Google Scholar
• BURDETT V: Streptococcal tetracycline resistance mediated at the level of protein synthesis. J. Bacteria (1986)165 (3):564–569.
   PubMedGoogle Scholar
• DANTLEY KA, DANNELLY HK, BURDETT V: Binding interaction between Tet(M) and the ribosome: requirements for binding. J. Bacteria (1998) 180(16)4089–4092.
   Google Scholar
• BERGERON J, AMMIRATI M, DANLEY D et al.: Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(0)-mediated ribosomal protection. Antimicrob. Agents Chemother. (1996) 40(9):2226–2228.
   PubMedGoogle Scholar
• TRIEBER CA, BURKHARDT N, NIERHAUS KH, TAYLOR DE: Ribosomal protection from tetracycline mediated by Tet(0): Tet(0) interaction with ribosomes is GTP-dependent. Biol. Chem. (1998) 379:847–855.
   PubMed Web of Science ®Google Scholar
• GREENWALD RA, GOLUB LM: Biologic properties of non-antibiotic, chemically modified tetracyclines (CMTs): a structured, annotated bibliography. Cum Med. Chem. (2001) 8:237–242.
   PubMedGoogle Scholar
• •A review that organises and provides commentary on important literature devoted to non-antibacterial uses of the tetracyclines. This is the lead article of an entire journal volume devoted to this topic.
   Google Scholar
• STORK G, LA CLAIR JJ, SPARGO P, NARGUND RP, TOTAH N: Stereocontrolled synthesis of (c11)-1 2a-deoxytetracycline. J. Am. Chem. Soc. (1996) 118(22):5304–5305.
   Google Scholar
• KORST JJ, JOHNSTON JD, BUTLER K, BIANCO EJ, CONOVER LH, WOODWARD RB: The total synthesis of (c11)-6-demethy1-6-deoxytetracycline. J. Am. Chem. Soc. (1968) 90(2):439–456.
   Google Scholar
• KUNIAKI T, YOSHIMOTO T, HIROKI G, OKADO Y, TAKAHASHI M: The first total synthesis if natural 0 tetracycline. Chem. Lett. (2000) 6:646–647.
   Google Scholar